Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioequivalence studies: Biowaivers01:13

Bioequivalence studies: Biowaivers

In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Calcium-Deficient hydroxyapatite as a bone graft material: From hydrated-layer chemistry to clinical performance.

Acta biomaterialia·2026
Same author

Copper-doped β-tricalcium phosphate: synthesis, characterization, and <i>in vitro</i> osteoclastic resorption.

Materials today. Bio·2026
Same author

Release kinetics of growth factors loaded into β-TCP ceramics in an <i>in vitro</i> model.

Frontiers in bioengineering and biotechnology·2024
Same author

Optimization of Parameters for Atom Probe Tomography Analysis of β-Tricalcium Phosphates.

Microscopy and microanalysis : the official journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada·2024
Same author

A model approach to show that monocytes can enter microporous β-TCP ceramics.

BMC biotechnology·2024
Same author

Awareness for artifacts in fluorescence microscopy of β-TCP.

BMC research notes·2024
Same journal

Oral colon-targeted micro-nano formulation engineered in microfluid for synergistic therapy of inflammatory bowel disease.

Biomaterials·2026
Same journal

Manganese@Gold cluster-coordinated covalent organic frameworks-based artificial metalloenzymes with cascade biocatalysis and amplified systemic stimulation to combat malignant tumor metastasis.

Biomaterials·2026
Same journal

Remodeling TME via feedback-driven photothermal-ferroptosis-immune cascade.

Biomaterials·2026
Same journal

Corrigendum to "Photodynamic therapy produces enhanced efficacy of antitumor immunotherapy by simultaneously inducing intratumoral release of sorafenib" [Biomaterials 2020, 240, 119845].

Biomaterials·2026
Same journal

Mg-integrated octopus-inspired hydrogel dressing enables autonomous adhesion and wound closure for enhanced healing via sequential microenvironment regulation.

Biomaterials·2026
Same journal

Engineering miRNA-223 nanocomplexes via bioorthogonal self-assembly for precision therapy of intervertebral disc degeneration.

Biomaterials·2026
See all related articles

Related Experiment Video

Updated: Jun 26, 2026

Screening for Endocrine Activity in Water Using Commercially-available In Vitro Transactivation Bioassays
08:00

Screening for Endocrine Activity in Water Using Commercially-available In Vitro Transactivation Bioassays

Published on: December 4, 2016

Can bioactivity be tested in vitro with SBF solution?

Marc Bohner1, Jacques Lemaitre

  • 1RMS Foundation, Bischmattstrasse 12, CH-2544 Bettlach, Switzerland. marc.bohner@rms-foundation.ch

Biomaterials
|January 30, 2009
PubMed
Summary
This summary is machine-generated.

The simulated body fluid (SBF) test is widely used to assess material bioactivity, but current data is insufficient to validate its efficacy. Improvements in testing methods are needed for reliable bioactivity assessment.

More Related Videos

Measuring Volatile and Non-volatile Antifungal Activity of Biocontrol Products
06:47

Measuring Volatile and Non-volatile Antifungal Activity of Biocontrol Products

Published on: December 5, 2020

Related Experiment Videos

Last Updated: Jun 26, 2026

Screening for Endocrine Activity in Water Using Commercially-available In Vitro Transactivation Bioassays
08:00

Screening for Endocrine Activity in Water Using Commercially-available In Vitro Transactivation Bioassays

Published on: December 4, 2016

Measuring Volatile and Non-volatile Antifungal Activity of Biocontrol Products
06:47

Measuring Volatile and Non-volatile Antifungal Activity of Biocontrol Products

Published on: December 5, 2020

Area of Science:

  • Biomaterials Science
  • Materials Science
  • Biomineralization Studies

Background:

  • The simulated body fluid (SBF) solution is widely adopted for evaluating material bioactivity.
  • An increasing number of scientific publications utilize SBF testing, reflecting community acceptance.
  • This widespread use suggests an accepted paradigm for material bioactivity assessment.

Purpose of the Study:

  • To critically evaluate the scientific basis for using SBF to test material bioactivity.
  • To identify limitations and areas for improvement in the current SBF testing methodology.
  • To provide theoretical arguments and factual evidence regarding SBF test validity and execution.

Main Methods:

  • Literature review and critical analysis of existing studies using SBF.
  • Theoretical argumentation based on established scientific principles.
  • Identification of common practices in SBF test execution.

Main Results:

  • Insufficient scientific data currently supports the assumption that SBF accurately reflects in vivo bioactivity.
  • Existing SBF testing protocols often lack standardization and contain methodological flaws.
  • The interpretation of SBF test results may be unreliable due to these limitations.

Conclusions:

  • The current scientific evidence does not fully support the use of SBF as a definitive test for material bioactivity.
  • Significant improvements in the methodology and standardization of SBF tests are required.
  • Further research is necessary to validate and refine SBF testing for accurate bioactivity assessment.